The Medical Director and Clinician Leadership Forum is designed to bring medical directors and other executive clinical leaders together to learn from nationally recognized practitioners and thought leaders. Faculty will share their insights into topics that are critical to the management of large patient populations.

This activity will explore recent advances in the diagnosis and treatment of KLA and other lymphatic conditions, including current clinical trials. It will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s).

During this activity, presenters will discuss CF and the different genetic etiologies and examine how an individual’s genetic profile can be utilized to develop a personalized treatment plan. The role that an informed interprofessional health care team can play in improved disease outcomes will also be examined. 

In this activity, participants will explore the pandemic’s impacts on individuals’ mental health, including the increasing risks for, and prevalence of, stress, anxiety and post-traumatic stress disorder, especially for special populations such as front-line personnel (i.e., health care professionals (HCPs), teachers and funeral directors), children and the millennial and geriatric populations. In addition, participants will review the multifaceted effects of the pandemic on the behavioral health care delivery system, specifically regarding access to care, delivery of services and digital health utilization. The implications for current and future utilization of delivery modalities, such as telehealth, behavioral health coaching and other mental health care management strategies will be discussed, taking into consideration the behavioral health care concerns that have emerged during this transitional time in response to the transforming health care landscape and the population’s evolving mental health care needs.